Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)
HKD 0.28
(0.0%)
HKD 0.28
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 77.62 Million CNY | -12.94% |
| 2022 | 89.15 Million CNY | 39.52% |
| 2021 | 63.9 Million CNY | 55.42% |
| 2020 | 41.11 Million CNY | 212.18% |
| 2019 | 13.17 Million CNY | 106.75% |
| 2018 | 6.37 Million CNY | 164.59% |
| 2017 | 2.4 Million CNY | 105.26% |
| 2016 | -45.74 Million CNY | 24.56% |
| 2015 | -60.63 Million CNY | -255.82% |
| 2014 | 38.91 Million CNY | -34.25% |
| 2013 | 59.19 Million CNY | -1.27% |
| 2012 | 59.95 Million CNY | -1.98% |
| 2011 | 61.16 Million CNY | 72.25% |
| 2010 | 35.5 Million CNY | 497.45% |
| 2009 | 5.94 Million CNY | -92.39% |
| 2008 | 78.11 Million CNY | -1.27% |
| 2007 | 79.11 Million CNY | -16.51% |
| 2006 | 94.76 Million CNY | 160.54% |
| 2005 | 36.37 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 80.45 Million CNY | 14.76% |
| 2024 Q1 | 80.45 Million CNY | 3.65% |
| 2023 Q4 | 77.62 Million CNY | 35.61% |
| 2023 Q2 | 88.52 Million CNY | 1128.01% |
| 2023 Q1 | 7.2 Million CNY | -91.91% |
| 2023 Q3 | 57.23 Million CNY | -35.34% |
| 2023 FY | 77.62 Million CNY | -12.94% |
| 2022 Q1 | 27.43 Million CNY | -57.06% |
| 2022 Q4 | 89.15 Million CNY | 25.35% |
| 2022 Q3 | 71.12 Million CNY | -20.21% |
| 2022 Q2 | 89.13 Million CNY | 224.86% |
| 2022 FY | 89.15 Million CNY | 39.52% |
| 2021 FY | 63.9 Million CNY | 55.42% |
| 2021 Q2 | 32.05 Million CNY | -9.79% |
| 2021 Q1 | 35.53 Million CNY | -13.59% |
| 2021 Q4 | 63.9 Million CNY | 0.0% |
| 2020 Q4 | 41.11 Million CNY | 0.0% |
| 2020 FY | 41.11 Million CNY | 212.18% |
| 2020 Q2 | 5.92 Million CNY | -75.57% |
| 2020 Q1 | 24.24 Million CNY | 84.09% |
| 2019 Q2 | 31.31 Million CNY | -39.96% |
| 2019 Q1 | 52.15 Million CNY | 718.7% |
| 2019 Q4 | 13.17 Million CNY | 0.0% |
| 2019 FY | 13.17 Million CNY | 106.75% |
| 2018 Q2 | -479.68 Thousand CNY | -101.28% |
| 2018 FY | 6.37 Million CNY | 164.59% |
| 2018 Q1 | 37.59 Million CNY | 1461.32% |
| 2018 Q4 | 6.37 Million CNY | 0.0% |
| 2017 Q2 | 25.25 Million CNY | -70.55% |
| 2017 FY | 2.4 Million CNY | 105.26% |
| 2017 Q4 | 2.4 Million CNY | 0.0% |
| 2017 Q1 | 85.74 Million CNY | 287.44% |
| 2016 FY | -45.74 Million CNY | 24.56% |
| 2016 Q1 | 105.63 Million CNY | 274.21% |
| 2016 Q4 | -45.74 Million CNY | 0.0% |
| 2016 Q2 | 170.29 Thousand CNY | -99.84% |
| 2015 FY | -60.63 Million CNY | -255.82% |
| 2015 Q4 | -60.63 Million CNY | 0.0% |
| 2015 Q2 | -15.47 Million CNY | -131.98% |
| 2015 Q1 | 48.38 Million CNY | 24.33% |
| 2014 Q2 | 52.64 Million CNY | 22.12% |
| 2014 Q1 | 43.1 Million CNY | -27.17% |
| 2014 Q4 | 38.91 Million CNY | 0.0% |
| 2014 FY | 38.91 Million CNY | -34.25% |
| 2013 Q4 | 59.19 Million CNY | 0.0% |
| 2013 Q1 | 23.34 Million CNY | -61.06% |
| 2013 FY | 59.19 Million CNY | -1.27% |
| 2013 Q2 | 83.4 Million CNY | 257.28% |
| 2012 FY | 59.95 Million CNY | -1.98% |
| 2012 Q2 | 48.45 Million CNY | 0.0% |
| 2012 Q4 | 59.95 Million CNY | 0.0% |
| 2011 Q2 | 79.08 Million CNY | 0.0% |
| 2011 FY | 61.16 Million CNY | 72.25% |
| 2011 Q4 | 61.16 Million CNY | 0.0% |
| 2011 Q3 | - CNY | -100.0% |
| 2010 Q4 | 35.5 Million CNY | 0.0% |
| 2010 FY | 35.5 Million CNY | 497.45% |
| 2010 Q2 | 43.37 Million CNY | 0.0% |
| 2009 FY | 5.94 Million CNY | -92.39% |
| 2008 FY | 78.11 Million CNY | -1.27% |
| 2007 FY | 79.11 Million CNY | -16.51% |
| 2006 FY | 94.76 Million CNY | 160.54% |
| 2005 FY | 36.37 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|